STIMIT AG

Swiss Startup - STIMIT Profile Main Image
STIMIT empowers patients to breathe.

Mechanical ventilation is life-saving, especially these days. However during mechanical ventilation, natural lung function is suppressed, and the diaphragm (core breathing muscle) becomes inactive and weak. Often too weak for sufficient breathing, so that patients become adapted to and sometimes dependent on mechanical ventilation (weaning required).

STIMIT is developing therapy and medical device to empower patients in intensive care to breathe. The startups technology can non-invasively activate the body's own breathing function. The therapy goal is to maintain breathing muscle function during ventilation, to minimize life-threatening damage to the lungs from mechanical ventilation, and shorten the duration of ventilation.

Let's treat more ventilated patients in less time.

News

26.09.2022 Preise für Planted und Stimit (startupticker.ch)
16.12.2021 Schneller wieder selbständig atmen (startupticker.ch)
06.04.2021 Exit für STIMIT-Gründer (startupticker.ch)
18.02.2020 10 Swiss Medtech Startups to Watch in 2020 (venturelab.swiss)

Videos and Presentations


A Kickers' World, Episode 8 Stimit Founder Ronja Bruhn


STIMIT video

https://youtu.be/z_i7gDcEqX0